Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)

Elizabeth A. Johnson, Randolph S. Marks, Sumithra J. Mandrekar, Shauna L. Hillman, Mark D. Hauge, Mitchel D. Bauman, Edward J. Wos, Dennis F. Moore, John W. Kugler, Harold E. Windschitl, David L. Graham, Albert M. Bernath, Tom R. Fitch, Gamini S. Soori, James R. Jett, Alex A. Adjei, Edith A. Perez

Research output: Contribution to journal › Article › peer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)'. Together they form a unique fingerprint.

Medicine & Life Sciences